VRelax: reducing impact of stress in patients with psychiatric disorders - a virtual reality pilot study
Completed
- Conditions
- psychiatric disordersstress10037173
- Registration Number
- NL-OMON43327
- Lead Sponsor
- niversitair Centrum Psychiatrie
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 30
Inclusion Criteria
- Patient in clinical department of mood/anxiety disorders or psychotic disorders
- DSM-IV diagnosis of depressive disorder, anxiety disorder or psychotic disorder
- Age >18
Exclusion Criteria
- DSM-IV diagnosis of substance abuse or dependence
- Specific phobia dolphins or water
- Benzodiazepine use > 10 mg / day diazepam equivalent
- Involuntary admission (IBS or RM)
- Diagnosis of epilepsy or organic brain damage
- Insufficient command of Dutch language
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method